Back
iShares Global Comm Services ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
56
IXP
iShares Global Comm Services ETF
Last Price:
92.54
Seasonality Move:
1.89%
Sell
39
HALO
Halozyme Therapeutics
Last Price:
42.56
Seasonality Move:
17.03%
Buy
56
iShares Global Comm Services ETF (IXP)
is a Buy
Is iShares Global Comm Services ETF a Buy, Sell or Hold?
- The current iShares Global Comm Services ETF [IXP] share price is $94.86. The Score for IXP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- IXP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IXP Stock Price Chart
What is iShares Global Comm Services ETF's stock price today?
-
The iShares Global Comm Services ETF share price today is $94.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
IXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 50.69 | Buy |
Chaikin Money Flow: | -2567 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 30.2 | Sell |
Chaikin Money Flow: | -7140517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
IXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.35 | Sell |
20-day SMA: | 94.87 | Sell |
50-day SMA: | 93.38 | Buy |
200-day SMA: | 87.58 | Buy |
8-day EMA: | 95.81 | Sell |
20-day EMA: | 95.15 | Sell |
50-day EMA: | 93.48 | Buy |
200-day EMA: | 87.18 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.53 | Sell |
20-day SMA: | 54.48 | Sell |
50-day SMA: | 56.18 | Sell |
200-day SMA: | 48.93 | Sell |
8-day EMA: | 55 | Sell |
20-day EMA: | 55.41 | Sell |
50-day EMA: | 55.64 | Sell |
200-day EMA: | 50.73 | Sell |
iShares Global Comm Services ETF Earnings Growth & IXP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
iShares Global Comm Services ETF Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |